Breaking Down Vir Biotechnology: 6 Analysts Share Their Views
Breaking Down Vir Biotechnology: 6 Analysts Share Their Views
解析vir biotechnology：6位分析师分享了他们的观点
The standing of Vir Biotechnology among financial experts is revealed through an in-depth...In the latest quarter, 6 analysts provided ratings for Vir Biotechnology (NASDAQ:VIR), showcasing a mix of bullish and bearish perspectives.
在最新的一季度中，6名分析师提供了Vir Biotechnology（NASDAQ：VIR）的评级，展示了看好和看淡的观点的混合。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $65.33, a high estimate of $110.00, and a low estimate of $15.00. Observing a 2.08% increase, the current average has risen from the previous average price target of $64.00.
分析师分析的12个月价格目标提供了洞察，平均目标为65.33美元，高估目标为110.00美元，低估目标为15.00美元。当前平均价值从先前的平均价格目标64.00美元上升了2.08％。
Decoding Analyst Ratings: A Detailed Look
分析师评级解读：详细解析
The standing of Vir Biotechnology among financial experts is revealed through an in-depth...
通过对最近的分析师行动进行深...
登录免费看全文
登录/注册